ASE TECHNOLOGY HOLDING -ADR(NYSE:ASX) stock News

ASX Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: OTC Markets - Mentions: OTCM -

OTC Markets Group Welcomes Alkane Resources Limited to OTCQX

7 days ago - By: OTC Markets - Mentions: OTCM -

OTC Markets Group Welcomes Talga Group Ltd. to OTCQX

8 days ago - By: Benzinga - Mentions: BSAC BGC RMNI MTZ ...

Earnings Scheduled For July 31, 2025

8 days ago - By: Benzinga

A Peek at ASE Tech Holding Co's Future Earnings

a month ago - By: ASE Technology Holding Co., Ltd.

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

2 months ago - By: ASE Technology Holding Co., Ltd.

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

8 days ago - By: ASE Technology Holding Co., Ltd.

ASE Technology Holding Co., Ltd. Reports Its Unaudited Consolidated Financial Results for the Second Quarter of 2025

9 days ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

11 days ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy

15 days ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

3 months ago - By: ASE Technology Holding Co., Ltd.

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

21 days ago - By: OTC Markets - Mentions: OTCM -

OTC Markets Group Welcomes Andean Silver Ltd to OTCQX

a month ago - By: Virtual Investor Conferences - Mentions: - TRSO DGXX DGX.CA ...

AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing

2 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

Alterity Therapeutics to Provide Corporate Update in Fireside Chat

4 months ago - By: ASE Technology Holding Co., Ltd.

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

2 months ago - By: Life360, Inc. - Mentions: - LIF

Life360 Enhances Ad Platform With Launch of Place Ads and Uplift, Redefining Real-World Targeting and Measurement

2 months ago - By: Life360, Inc. - Mentions: - LIF

Life360 Announces Closing of Upsized $320 Million Offering of 0.00% Convertible Senior Notes

2 months ago - By: Life360, Inc. - Mentions: - LIF

Life360 Announces Pricing of Upsized Convertible Senior Notes Offering

2 months ago - By: Life360, Inc. - Mentions: - LIF

Life360 Proposes Convertible Senior Notes Offering

2 months ago - By: Advanced Semiconductor Engineering, Inc.

ASE Announces FOCoS-Bridge With TSV; Latest Package Technology Reduces Power Loss by 3x for Next-Generation AI and HPC Applications

3 months ago - By: Life360, Inc. - Mentions: - LIF

Life360 Reports Record Q1 2025 Results

3 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

Alterity Therapeutics Prominently Featured at the International MSA Congress

3 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

3 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy

3 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

Appendix 4C – Q3 FY25 Quarterly Cash Flow Report

3 months ago - By: ASE Technology Holding Co., Ltd.

ASE Technology Holding Co., Ltd. Reports Its Unaudited Consolidated Financial Results for the First Quarter of 2025

3 months ago - By: Yahoo Finance - Mentions: LLY VKTX REGN SNY ...

Why Viking Therapeutics Stock Popped Again Today

3 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium

4 months ago - By: Yahoo Finance - Mentions: GFI KR

Gold starts coming back to Switzerland from US after exclusion from Trump's tariffs

4 months ago - By: Yahoo Finance

Is ASE Technology Holding (ASX) Worth Buying on the China H20 Chip Sale Ban?

4 months ago - By: Yahoo Finance - Mentions: GS STZ BJ KR ...

Is Constellation Brands, Inc. (STZ) the Best Large-Cap Value Stock to Buy as the Recession Hits?

4 months ago - By: Yahoo Finance - Mentions: PDD FN AMAT KR ...

PDD Holdings Inc. (NASDAQ:PDD): A Bargain Buy

4 months ago - By: ASE Technology Holding Co., Ltd.

ASE Technology Holding Co Honors Outstanding Suppliers of 2024

4 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

4 months ago - By: ALTERITY THERAPEUTICS LIMITED - Mentions: - ATHE

ASE TECHNOLOGY HOLDING -ADR (ASX) Stock News

ASX Latest News, Press Relases and Analysis

OTC Markets Group Welcomes Alkane Resources Limited to OTCQX

OTC Markets Group Welcomes Talga Group Ltd. to OTCQX

Earnings Scheduled For July 31, 2025

A Peek at ASE Tech Holding Co's Future Earnings

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

ASE Technology Holding Co., Ltd. Reports Its Unaudited Consolidated Financial Results for the Second Quarter of 2025

Appendix 4C – Q4 FY25 Quarterly Cash Flow Report

Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy

Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

OTC Markets Group Welcomes Andean Silver Ltd to OTCQX

AI & Technology Virtual Investor Conference: Presentations Now Available for Online Viewing

Alterity Therapeutics to Provide Corporate Update in Fireside Chat

ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*

Life360 Enhances Ad Platform With Launch of Place Ads and Uplift, Redefining Real-World Targeting and Measurement

Life360 Announces Closing of Upsized $320 Million Offering of 0.00% Convertible Senior Notes

Life360 Announces Pricing of Upsized Convertible Senior Notes Offering

Life360 Proposes Convertible Senior Notes Offering

ASE Announces FOCoS-Bridge With TSV; Latest Package Technology Reduces Power Loss by 3x for Next-Generation AI and HPC Applications

Life360 Reports Record Q1 2025 Results

Alterity Therapeutics Prominently Featured at the International MSA Congress

Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy

Appendix 4C – Q3 FY25 Quarterly Cash Flow Report

ASE Technology Holding Co., Ltd. Reports Its Unaudited Consolidated Financial Results for the First Quarter of 2025

Why Viking Therapeutics Stock Popped Again Today

Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium

Gold starts coming back to Switzerland from US after exclusion from Trump's tariffs

Is ASE Technology Holding (ASX) Worth Buying on the China H20 Chip Sale Ban?

Is Constellation Brands, Inc. (STZ) the Best Large-Cap Value Stock to Buy as the Recession Hits?

PDD Holdings Inc. (NASDAQ:PDD): A Bargain Buy

ASE Technology Holding Co Honors Outstanding Suppliers of 2024

Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting

Alterity Therapeutics to Deliver an Oral Presentation of the Positive ATH434 Phase 2 Trial Results at the American Academy of Neurology Annual Meeting